Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin receptor A2 (EphA2) is a receptor tyrosine kinase involved in cell migration, adhesion, proliferation, and differentiation. It interacts with ephrin-A ligands and plays a crucial role in developmental processes and tissue homeostasis. EphA2 is frequently overexpressed in various cancers, promoting tumor growth and metastasis. It also serves as an entry point for certain viruses and can contribute to drug resistance. Targeting EphA2 is being explored as a therapeutic strategy.
Agonist-mediated receptor activation, Receptor inhibition via small molecules, Aptamer targeting
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin Receptor A2 (EphA2).